Revised trading statement and further cautionary announcement BioScience Brands Limited (Incorporated in the Republic of South Africa) (Registration number: 1987/001222/06) (JSE code: BIO ISIN: ZAE000115036) (BioScience or the company) Revised trading statement and further cautionary announcement Shareholders are referred to the trading statement dated 4 March 2013 in which shareholders were advised that the loss per share and headline loss per shares for the six months ended 31 December 2012 are expected to be more than 20% worse than that of the previous interim period ended 31 December 2011. The company is busy finalising its interim financial results for the period ending 31 December 2012. Shareholders are advised that the results for the six months ended 31 December 2012 are expected to be in the range of between 0.50 and 0.60 cents loss per share, and in the range of between 0.05 and 0.15 cents headline loss per share. The financial information on which this trading statement is based has not been reviewed or reported on by the Group`s external auditors. BioSciences interim financial results will be released on SENS on 28 March 2013. Renewal of cautionary announcement Shareholders are referred to the cautionary announcement of 4 March 2013 in respect of negotiations to dispose of the Muscle Science business and related assets. These negotiations are continuing and shareholders are advised to continue exercising caution when dealing in the companys shares until a full announcement is made. 26 March 2013 Johannesburg Designated Adviser Exchange Sponsors Date: 27/03/2013 07:15:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.